337 related articles for article (PubMed ID: 16433450)
21. Progress and prospects: gene therapy for inherited immunodeficiencies.
Qasim W; Gaspar HB; Thrasher AJ
Gene Ther; 2009 Nov; 16(11):1285-91. PubMed ID: 19776764
[TBL] [Abstract][Full Text] [Related]
22. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
Dropulic B
Curr Hematol Rep; 2005 Jul; 4(4):300-4. PubMed ID: 16009045
[TBL] [Abstract][Full Text] [Related]
23. [Gene therapy for adenosine deaminase deficiency].
Sakiyama Y
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy using hematopoietic stem cells.
Kohn DB
Curr Opin Mol Ther; 1999 Aug; 1(4):437-42. PubMed ID: 11713757
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy for hematopoietic and immune disorders.
Kohn DB
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S55-8. PubMed ID: 8971410
[TBL] [Abstract][Full Text] [Related]
26. Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?
Mikkers H; Pike-Overzet K; Staal FJ
Pediatr Res; 2012 Apr; 71(4 Pt 2):427-32. PubMed ID: 22430378
[TBL] [Abstract][Full Text] [Related]
27. In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.
Adjali O; Marodon G; Steinberg M; Mongellaz C; Thomas-Vaslin V; Jacquet C; Taylor N; Klatzmann D
J Clin Invest; 2005 Aug; 115(8):2287-95. PubMed ID: 16075064
[TBL] [Abstract][Full Text] [Related]
28. Retroviral transduction of IL-7Ralpha into IL-7Ralpha-/- bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia.
Jiang Q; Li WQ; Aiello FB; Klarmann KD; Keller JR; Durum SK
Gene Ther; 2005 Dec; 12(24):1761-8. PubMed ID: 16208423
[TBL] [Abstract][Full Text] [Related]
29. Update on gene therapy for hereditary hematological disorders.
Herzog RW; Arruda VR
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):215-32. PubMed ID: 15030282
[TBL] [Abstract][Full Text] [Related]
30. Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold.
Buchholz CJ; Cichutek K
J Gene Med; 2006 Oct; 8(10):1274-6. PubMed ID: 17001625
[TBL] [Abstract][Full Text] [Related]
31. Gene therapy for primary immunodeficiencies.
Fischer A; Hacein-Bey Abina S; Touzot F; Cavazzana M
Clin Genet; 2015 Dec; 88(6):507-15. PubMed ID: 25708106
[TBL] [Abstract][Full Text] [Related]
32. [Gene therapy for severe combined immunodeficiency].
Petersen LB; Jensen TG
Ugeskr Laeger; 2010 Jun; 172(23):1756-8. PubMed ID: 20534204
[TBL] [Abstract][Full Text] [Related]
33. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
Taupin P
IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
[TBL] [Abstract][Full Text] [Related]
34. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
Kang EM; Tisdale JF
Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
[TBL] [Abstract][Full Text] [Related]
35. A new direction for gene therapy: intrathymic T cell-specific lentiviral gene transfer.
Seggewiss R; Dunbar CE
J Clin Invest; 2005 Aug; 115(8):2064-7. PubMed ID: 16075048
[TBL] [Abstract][Full Text] [Related]
36. Retroviral vectors: new applications for an old tool.
Barquinero J; Eixarch H; Pérez-Melgosa M
Gene Ther; 2004 Oct; 11 Suppl 1():S3-9. PubMed ID: 15454951
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy. Panel urges limits on X-SCID trials.
Kaiser J
Science; 2005 Mar; 307(5715):1544-5. PubMed ID: 15761128
[No Abstract] [Full Text] [Related]
38. Successes and risks of gene therapy in primary immunodeficiencies.
Chinen J; Puck JM
J Allergy Clin Immunol; 2004 Apr; 113(4):595-603; quiz 604. PubMed ID: 15100660
[TBL] [Abstract][Full Text] [Related]
39. In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency.
Carbonaro DA; Jin X; Petersen D; Wang X; Dorey F; Kil KS; Aldrich M; Blackburn MR; Kellems RE; Kohn DB
Mol Ther; 2006 Jun; 13(6):1110-20. PubMed ID: 16651028
[TBL] [Abstract][Full Text] [Related]
40. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
Hershfield MS
Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
